Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 17 Patents
Pyrazolo[4,3-d]pyrimidines as antitumor agents

13-02-2024 • US-11897886-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Substituted pyrrolo,-furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof

12-12-2023 • US-11840539-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient

04-04-2023 • US-11618758-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Substituted bicyclic pyrimidine compounds with tubulin and multiple receptor inhibition

07-02-2023 • US-11572363-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents

12-07-2022 • US-11384084-B2

GANGJEE, ALEEM • MATHERLY, LARRY H.

Wayne State University • Duquesne University of the Holy Spirit

Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibitor and antitumor agents

21-09-2021 • US-11124520-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Pyrimidine compounds and pyrimido indole compounds and methods of use

07-09-2021 • US-11111252-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof

17-08-2021 • US-11091500-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same

03-08-2021 • US-11078214-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same

06-07-2021 • US-11053252-B2

GANGJEE, ALEEM • MATHERLY, LARRY H.

Wayne State University • Duquesne University of the Holy Spirit

Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibition and antitumor agents

26-03-2019 • US-10239880-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Pyrimidine compounds and pyrimido indole compounds and methods of use

19-03-2019 • US-10233194-B2

GANGJEE, ALEEM

Duquesne Unversity Of Holy Spirit • Duquesne University of the Holy Spirit

Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof

19-02-2019 • US-10208051-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as anti-tumor agents

29-01-2019 • US-10189853-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Substituted pyrimidine compounds and methods of use and manufacture

01-01-2019 • US-10167287-B2

GANGJEE, ALEEM • MATHERLY, LARRY H.

Wayne State University • Duquesne University of the Holy Spirit

Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof

11-09-2018 • US-10072019-B2

GANGJEE, ALEEM

Duquesne University of the Holy Spirit

Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same

19-06-2018 • US-10000498-B2

GANGJEE, ALEEM • MATHERLY, LARRY H.

Wayne State University • Duquesne University of the Holy Spirit

Owner
Inventors
Assignee
Patent Type
Publication Year

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.